Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer

Emily S. Tonorezos, Melissa M. Hudson, Angela B. Edgar, Leontien C. Kremer, Charles A. Sklar, W. Hamish B. Wallace, Kevin C. Oeffinger

Onderzoeksoutput: Bijdrage aan tijdschriftArtikel recenserenpeer review

33 Citaten (Scopus)

Samenvatting

5 year survival for childhood and adolescent cancer in developed countries is now in excess of 80% and the number of survivors of cancer continues to increase worldwide. After completion of therapy, many of these survivors will face a lifelong risk of endocrine late effects. We summarise the available evidence related to the prevalence and risk factors for endocrine late effects among adult survivors of childhood and adolescent cancer. Present screening, surveillance, and treatment recommendations differ by country and region, so we also highlight the continued effort to harmonise the international guidelines for this population.

Originele taal-2Engels
Pagina's (van-tot)545-555
Aantal pagina's11
TijdschriftThe Lancet Diabetes and Endocrinology
Volume3
Nummer van het tijdschrift7
DOI's
StatusGepubliceerd - 1 jul. 2015
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer'. Samen vormen ze een unieke vingerafdruk.

Citeer dit